Differential effects of trimetazidine on vascular smooth muscle cell and endothelial cell in response to carotid artery balloon injury in diabetic rats

International Journal of Cardiology

Volumn 167, Issue 1, 2013, Pages 126-133

  Yoon, Ji Won ^a,b   Cho, Bong Jun ^a   Park, Ho Seon ^b   Kang, Seon Mee ^a,b   Choi, Sung Hee ^a,b   Jang, Hak Chul ^a,b   Shin, Hayley ^c   Lee, Min Jin ^d   Kim, Young Bum ^e   Park, Kyong Soo ^b   Lim, Soo ^a,b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University   (South Korea)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d HARVARD UNIVERSITY   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Inflammation; Oxidative stress; Restenosis; Trimetazidine

Indexed keywords

CASPASE 3; REACTIVE OXYGEN METABOLITE; SODIUM CHLORIDE; STREPTOZOCIN; TRIMETAZIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY BALLOON INJURY; CAROTID ARTERY INJURY; CAROTID ARTERY OBSTRUCTION; CELL PROLIFERATION; CELL SPECIFICITY; CELL SURVIVAL; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; ENDOTHELIUM CELL; GROWTH INHIBITION; HISTOGENESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MIGRATION INHIBITION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTECTION; RAT; REENDOTHELIALIZATION; RESTENOSIS; SMOOTH MUSCLE FIBER; STREPTOZOCIN DIABETES; TREATMENT DURATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; CAROTID ARTERY INJURIES; CELL PROLIFERATION; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RATS; RATS, INBRED OLETF; RATS, LONG-EVANS; RATS, SPRAGUE-DAWLEY; TRIMETAZIDINE; VASODILATOR AGENTS;

EID: 84878604298     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.12.061     Document Type: Article

References (45)

1. A.E. Rodriguez, A.O. Maree, and J. Mieres Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry Eur Heart J 28 2007 2118 2125
2. D. Aronson, Z. Bloomgarden, and E.J. Rayfield Potential mechanisms promoting restenosis in diabetic patients J Am Coll Cardiol 27 1996 528 535
3. A. Onay-Besikci, and S.A. Ozkan Trimetazidine revisited: a comprehensive review of the pharmacological effects and analytical techniques for the determination of trimetazidine Cardiovasc Ther 26 2008 147 165
4. P.F. Kantor, A. Lucien, and R. Kozak The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase Circ Res 86 2000 580 588
5. A. Onay-Besikci, S. Guner, and E. Arioglu The effects of chronic trimetazidine treatment on mechanical function and fatty acid oxidation in diabetic rat hearts Can J Physiol Pharmacol 85 2007 527 535
6. R. Belardinelli, M. Solenghi, and L. Volpe Trimetazidine improves endothelial dysfunction in chronic heart failure: an antioxidant effect Eur Heart J 28 2007 1102 1108
7. K.H. Park, W.J. Park, and M.K. Kim Effects of trimetazidine on endothelial dysfunction after sheath injury of radial artery Am J Cardiol 105 2010 1723 1727
8. C. Guarnieri, and C. Muscari Beneficial effects of trimetazidine on mitochondrial function and superoxide production in the cardiac muscle of monocrotaline-treated rats Biochem Pharmacol 37 1988 4685 4688
9. J.N. Fabiani, B. Farah, and A. Vuilleminot Chromosomal aberrations and neutrophil activation induced by reperfusion in the ischaemic human heart Eur Heart J 14 1993 12 17 Suppl G
10. V. Maupoil, L. Rochette, and A. Tabard Evolution of free radical formation during low-flow ischemia and reperfusion in isolated rat heart Cardiovasc Drugs Ther 4 Suppl. 4 1990 791 795
11. K. Mizushige, L. Yao, and T. Noma Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model Circulation 101 2000 899 907
12. A.W. Clowes, M.A. Reidy, and M.M. Clowes Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium Lab Invest 49 1983 327 333
13. P. Svoboda, S.H. Ko, and B. Cho Neopterin, a marker of immune response, and 8-hydroxy-2′-deoxyguanosine, a marker of oxidative stress, correlate at high age as determined by automated simultaneous high-performance liquid chromatography analysis of human urine Anal Biochem 383 2008 236 242
14. Y. Rikitake, S. Kawashima, and T. Yamashita Lysophosphatidylcholine inhibits endothelial cell migration and proliferation via inhibition of the extracellular signal-regulated kinase pathway Arterioscler Thromb Vasc Biol 20 2000 1006 1012
15. M. Takahashi, H. Okazaki, and Y. Ogata Lysophosphatidylcholine induces apoptosis in human endothelial cells through a p38-mitogen-activated protein kinase-dependent mechanism Atherosclerosis 161 2002 387 394
16. M. Matsubara, and K. Hasegawa Benidipine, a dihydropyridine-calcium channel blocker, prevents lysophosphatidylcholine-induced injury and reactive oxygen species production in human aortic endothelial cells Atherosclerosis 178 2005 57 66
17. M.M. Tarpey, and I. Fridovich Methods of detection of vascular reactive species: nitric oxide, superoxide, hydrogen peroxide, and peroxynitrite Circ Res 89 2001 224 236
18. V.J. Dzau, R.C. Braun-Dullaeus, and D.G. Sedding Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies Nat Med 8 2002 1249 1256
19. H. Tanaka, G. Sukhova, and D. Schwartz Proliferating arterial smooth muscle cells after balloon injury express TNF-alpha but not interleukin-1 or basic fibroblast growth factor Arterioscler Thromb Vasc Biol 16 1996 12 18
20. I.N. Lavrik, A. Golks, and P.H. Krammer Caspases: pharmacological manipulation of cell death J Clin Invest 115 2005 2665 2672
21. Z.S. Galis, and J.J. Khatri Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly Circ Res 90 2002 251 262
22. K.K. Griendling, and M. Ushio-Fukai Redox control of vascular smooth muscle proliferation J Lab Clin Med 132 1998 9 15
23. K. Satoh, P. Nigro, and B.C. Berk Oxidative stress and vascular smooth muscle cell growth: a mechanistic linkage by cyclophilin A Antioxid Redox Signal 12 2010 675 682
24. H. Cai, and D.G. Harrison Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress Circ Res 87 2000 840 844
25. S. Nikol, T.Y. Huehns, and B. Hofling Molecular biology and post-angioplasty restenosis Atherosclerosis 123 1996 17 31
26. W.S. Weintraub The pathophysiology and burden of restenosis Am J Cardiol 100 2007 3K 9K
27. A. Abizaid, R. Kornowski, and G.S. Mintz The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation J Am Coll Cardiol 32 1998 584 589
28. J. Daemen, and P.W. Serruys Drug-eluting stent update 2007: part I. A survey of current and future generation drug-eluting stents: meaningful advances or more of the same? Circulation 116 2007 316 328
29. M. Joner, A.V. Finn, and A. Farb Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 2006 193 202
30. N.P. Di, S. Chierchia, and A.A. Taccardi Trimetazidine improves post-ischemic recovery by preserving endothelial nitric oxide synthase expression in isolated working rat hearts Nitric Oxide 16 2007 228 236
31. J.L. Evans, I.D. Goldfine, and B.A. Maddux Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes Endocr Rev 23 2002 599 622
32. P. Kanellakis, P. Nestel, and A. Bobik Angioplasty-induced superoxide anions and neointimal hyperplasia in the rabbit carotid artery: suppression by the isoflavone trans-tetrahydrodaidzein Atherosclerosis 176 2004 63 72
33. P. Kanellakis, G. Pomilio, and C. Walker A novel antioxidant 3,7-dihydroxy-isoflav-3-ene (DHIF) inhibits neointimal hyperplasia after vessel injury attenuating reactive oxygen species and nuclear factor-kappaB signaling Atherosclerosis 204 2009 66 72
34. P.R. Moreno, V.H. Bernardi, and J. Lopez-Cuellar Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina Circulation 94 1996 3098 3102
35. F.G. Welt, E.R. Edelman, and D.I. Simon Neutrophil, not macrophage, infiltration precedes neointimal thickening in balloon-injured arteries Arterioscler Thromb Vasc Biol 20 2000 2553 2558
36. P.R. Moreno, J.T. Fallon, and A.M. Murcia Tissue characteristics of restenosis after percutaneous transluminal coronary angioplasty in diabetic patients J Am Coll Cardiol 34 1999 1045 1049
37. C. Rogers, F.G. Welt, and M.J. Karnovsky Monocyte recruitment and neointimal hyperplasia in rabbits. Coupled inhibitory effects of heparin Arterioscler Thromb Vasc Biol 16 1996 1312 1318
38. E. Mori, K. Komori, and T. Yamaoka Essential role of monocyte chemoattractant protein-1 in development of restenotic changes (neointimal hyperplasia and constrictive remodeling) after balloon angioplasty in hypercholesterolemic rabbits Circulation 105 2002 2905 2910
39. V. Pasceri, J.T. Willerson, and E.T. Yeh Direct proinflammatory effect of C-reactive protein on human endothelial cells Circulation 102 2000 2165 2168
40. D. Tousoulis, C. Antoniades, and C. Stefanadis Assessing inflammatory status in cardiovascular disease Heart 93 2007 1001 1007
41. E. Hu, P. Liang, and B.M. Spiegelman AdipoQ is a novel adipose-specific gene dysregulated in obesity J Biol Chem 271 1996 10697 10703
42. M.B. Schulze, I. Shai, and E.B. Rimm Adiponectin and future coronary heart disease events among men with type 2 diabetes Diabetes 54 2005 534 539
43. T. Pischon, C.J. Girman, and G.S. Hotamisligil Plasma adiponectin levels and risk of myocardial infarction in men JAMA 291 2004 1730 1737
44. M. Nishida, J.I. Miyagawa, and K. Tokunaga Early morphologic changes of atherosclerosis induced by ventromedial hypothalamic lesion in the spontaneously diabetic Goto-Kakizaki rat J Lab Clin Med 129 1997 200 207
45. D.A. Tulis Rat carotid artery balloon injury model Methods Mol Med 139 2007 1 30